Dr. Raajit Chanana

Senior Consultant

14 Years of Experience

Medical Oncologist

MBBS, MD, DM, Fellowship

Reg. No.:DMC/R/6939

Dharamshila Narayana Superspeciality Hospital, New Delhi

English, Hindi

Consultation Fee ₹ 1000

Book an Appointment Contact with Doctor

Confirm Your Consultation With Dr. Raajit Chanana

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

About Dr. Raajit Chanana

Dr. Raajit Chanana is a well-known and expert medical oncologist. He comes with about 14 years of experience to offer precision-based cancer treatment.
He is skilled in offering treatment services for different types of cancers, such as gastrointestinal, genitourinary, lung, and breast cancer.
He specializes in offering cancer treatment to his patients with
- Chemotherapy
- Immunotherapy
- Targeted therapy
- Precision medicine
Dr. Raaji Chanana pursued an MBBS from Maulana Azad Medical College in 2010. He then specialized in Internal Medicine by pursuing an MD from Lady Hardinge Medical College in 2014.
He also completed a DM in Medical Oncology at Tata Memorial Hospital in 2017.
He is an active leader and participant in clinical trials, hence offering novel and advanced methods of treatment for his patients.
Further, his constant attendance at international conferences keeps him up-to-date in practicing novel and innovative techniques and learning new skills.
Dr. Raajit Chanana is also focused on cancer awareness and imparting necessary education regarding its prevention and awareness.

Confirm Your Consultation With Dr. Raajit Chanana

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS - Maulana Azad Medical College, 2010
MD - Internal Medicine - Lady Hardinge Medical College, 2014
DM - Medical Oncology - Tata Memorial Hospital, 2017
Fellow in Paediatric Cardiac Surgery at Mater Medical School, University of Queensland, Brisbane

Training & Certificates

European Certified Medical Oncologist

OPD Schedule Of Dr. Raajit Chanana

Book Appointment

Past Experience

Specialist Registrar in Department of Medical Oncology at Tata Memorial Hospital, 2018
Clinical Associate in Paediatric Cardiac Surgery at Sevenhills Hospital Marol-Maroshi, Mumbai
Lecturer in School of Medicine, Mater Medical School under the University of Queensland, Brisbane

He has multiple publications to his credit. A few among them are:

Thorat, J., Sengar, M., Chanana, R., Kapoor, A., Singh, A., Bonda, A., ... & Jain, H. (2024). A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted EPOCH (+/? R) Regimen. Indian Journal of Hematology and Blood Transfusion, 40(1), 36–42.
Chandrakanth, M. V., Agarwala, V., Mondal, P., Chanana, R., Parthasarathy, K. M., Dutta, S., ... & Kumar, S. (2023). Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and metastatic squamous cell carcinoma of head and neck: a retrospective analysis from two institutions in India. F1000Research, 12, 802.
Jain, H., Kapoor, A., Sengar, M., Chanana, R., Menon, H., Sridhar, E., ... & Gujral, S. (2021). Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience. Indian Journal of Hematology and Blood Transfusion, 37, 379-385.
Jain, H., Rengaraj, K., Sharma, V., Bonda, A., Chanana, R., Thorat, J., ... & Sengar, M. (2020). Infection prevalence in adolescents and adults with acute myeloid leukemia treated in an Indian tertiary care center. JCO Global Oncology, 6, 1684-1695.
Agarwala, V., Chandrakanth, M. V., Mondal, P. K., & Chanana, R. (2020). 275P Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and metastatic squamous cell carcinoma of head and neck: A double institution retrospective analysis from India. Journal of Oncology, p. 31, S1350.
Sengar, M., Carr, R., Jain, H., Chanana, R., Rangarajan, V., Sridhar, E., ... & Laskar, S. (2020). Outcomes of T-lymphoblastic lymphoma treated with pediatric ALL-like protocol. Indian Journal of Cancer, 57(3), 262-266.
Chanana, R., Prabhash, K., Noroha, V., Joshi, A., Patil, V., & Nakti, D. (2018). A retrospective study was conducted to evaluate treatment outcomes of Pleural Mesothelioma treated in a tertiary care center in India. Annals of Oncology, 29, vii75-vii76.
Chanana, R., Noronha, V., Joshi, A., Patil, V., & Prabhash, K. (2018). The evolving role of immunotherapy in head-and-neck cancers: a systematic review. Journal of Head & Neck Physicians and Surgeons, 6(1), 2–11.